Clinical Trials Related to Thrombotic Microangiopathy

Related studies linked through entity extraction aliases.

Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy

Status: NOT_YET_RECRUITING
Phase: NA

N-Acetylcysteine as Therapy for Transplantation- Associated Thrombotic Microangiopathy

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE2/PHASE3

Thrombotic Microangiopathy (TMA) Associated With Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) In Adult Patients

Status: RECRUITING
Phase: N/A

French National Cohort MATRIX "Renal and Systemic Thrombotic Microangiopathy"

Status: UNKNOWN
Phase: N/A

Incidence of Snakebite Associated Thrombotic Microangiopathy & Role of Peripheral Blood Smear as a Predictor of Clinical Outcome

Status: UNKNOWN
Phase: N/A

Ravulizumab in Thrombotic Microangiopathy Associated With a Trigger

Status: TERMINATED
Phase: PHASE3

Study of Ravulizumab in Pediatric Participants With HSCT-TMA

Status: COMPLETED
Phase: PHASE3

Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell Transplant

Status: COMPLETED
Phase: PHASE3

Identification and Treatment of Thrombotic Microangiopathies in Allogeneic Stem Cell Transplants

Status: COMPLETED
Phase: N/A

OMS721 Compassionate Use in Patients With Thrombotic Microangiopathy

Status: AVAILABLE
Phase: N/A

Clinical Outcome Study of ARC1779 Injection in Patients With Thrombotic Microangiopathy

Status: TERMINATED
Phase: PHASE2

International Registry and Biorepository for TMA(Thrombotic Microangiopathy)

Status: TERMINATED
Phase: N/A